MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-04-2026
OrthoPediatrics Corp. Market Cap 2011-2026 | KIDS
As of April 28, 2026 OrthoPediatrics Corp. has a market cap of $ 369 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap OrthoPediatrics Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 437 M | 589 M | 620 M | 911 M | 1.15 B | 745 M | 695 M | 440 M | 83.3 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.15 B | 83.3 M | 630 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K |  USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.17 | -1.55 % | $ 119 M |  France |
 |
Electromed
ELMD
|
175 M | $ 25.61 | -1.52 % | $ 217 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 92.82 | -0.94 % | $ 12.6 B | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 13.19 | 0.84 % | $ 1.78 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.09 | -1.5 % | $ 1.27 M | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.25 | 0.77 % | $ 62.8 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 12.17 | -1.22 % | $ 482 M |  Curacao |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.64 | 5.38 % | $ 39.8 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 11.11 | -0.94 % | $ 315 M | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.38 | 1.26 % | $ 6.6 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Stryker Corporation
SYK
|
147 B | $ 324.55 | -1.36 % | $ 124 B | USA |
 |
Tactile Systems Technology
TCMD
|
640 M | $ 23.66 | -2.39 % | $ 541 M | USA |
 |
TELA Bio
TELA
|
32.4 M | $ 0.77 | -4.03 % | $ 36.1 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
TransMedics Group
TMDX
|
4.69 B | $ 104.23 | -3.6 % | $ 3.54 B | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 19.31 | -2.57 % | $ 1.31 B | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.25 | -2.23 % | $ 50.9 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 5.46 | -0.36 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Varex Imaging Corporation
VREX
|
502 M | $ 12.58 | -1.0 % | $ 521 M | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.73 | -1.06 % | $ 384 M | USA |
 |
Vivos Therapeutics
VVOS
|
15.1 M | $ 0.88 | 2.54 % | $ 9.04 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 63.09 | -0.5 % | $ 3.44 B |  Britain |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.05 | -2.78 % | $ 17.8 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 37.54 | -0.87 % | $ 1.17 B | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 55.68 | 1.11 % | $ 1.64 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 84.75 | -0.7 % | $ 2.94 B | USA |